Company Filing History:
Years Active: 2008-2009
Title: The Innovations of Jingchun Liu
Introduction
Jingchun Liu is a notable inventor based in Three Bridges, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for medical treatments. With a total of 2 patents, Liu's work focuses on addressing critical health issues.
Latest Patents
Liu's latest patents include innovative compounds that serve as α/α-adrenoreceptor modulators. The first patent details piperazine substituted cyclohexane-1,4-diamine compounds, which are designed for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms. This invention also encompasses pharmaceutical compositions, new processes for preparation, and methods of treatment. The second patent involves piperidinyl substituted cyclohexane-1,4-diamines, which share similar applications and benefits in medical treatments.
Career Highlights
Jingchun Liu is currently employed at Janssen Pharmaceutica NV, where he continues to innovate and develop new pharmaceutical solutions. His work has been instrumental in advancing treatments that improve patient quality of life.
Collaborations
Liu collaborates with esteemed colleagues such as George Chiu and Shengjian Li, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Jingchun Liu's contributions to pharmaceutical inventions highlight his commitment to improving healthcare through innovative solutions. His patents reflect a deep understanding of medical needs and a dedication to advancing treatment options.